Qlife CE-marks COVID-19 test
Qlife announces that the company has CE-marked its PCR test for Sars-CoV-2 for professional use on the mobile test platform Egoo.Health and that the commercialization can begin immediately.The current CE-mark applies to the professional use of the test platform Egoo.Health for sale on the European market. The next step is to place the COVID-19 test in strategic locations, where it can offer fast and reliable results with help from healthcare professionals. “With this CE-marking, Qlife has achieved an important regulatory milestone. Our COVID-19-test is one of the first mobile PCR tests